CCM
SPPI

CAAS Capital Management’s Spectrum Pharmaceuticals Inc SPPI Stock Holding History

CAAS Capital Management’s Portfolio SPPI Stock Details SPPI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-285,441
Closed -$123K – 1025
2022
Q3 		$123K Buy
+285,441
New +$280K 0.01% 692

Other funds holding SPPI

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
ACM
Alethea Capital Management Mercer Island, Washington $195M AUM 51.17% 1-Year Est. Return

CAAS Capital Management's SPPI Position: Q4 2022 in Review

CAAS Capital Management sold out of Spectrum Pharmaceuticals Inc (SPPI) in Q4 2022, closing a stake of 285,441 shares — an estimated $123K sold.

CAAS Capital Management first reported a position in SPPI in Q3 2022 and held it in 1 quarter. The position peaked at $123K in Q3 2022. 70 funds tracked by Wall St. Rank hold SPPI as of Q4 2022.

  • CAAS Capital Management reported no remaining Spectrum Pharmaceuticals Inc position as of Q4 2022 after selling out during the quarter.
  • CAAS Capital Management sold 285,441 Spectrum Pharmaceuticals Inc shares in Q4 2022, an estimated $123K.
  • CAAS Capital Management first reported a position in Spectrum Pharmaceuticals Inc in Q3 2022 and held it in 1 quarter.
  • CAAS Capital Management's Spectrum Pharmaceuticals Inc position peaked at $123K in Q3 2022.
  • 70 funds tracked by Wall St. Rank held Spectrum Pharmaceuticals Inc as of Q4 2022.

Based on CAAS Capital Management's 13F filing for Q4 2022, filed 14 Feb 2023.